HOLMS RUPERT DONALD has a total of 17 patent applications. Its first patent ever was published in 1994. It filed its patents most often in EPO (European Patent Office), Australia and Canada. Its main competitors in its focus markets biotechnology and pharmaceuticals are BIOTIE THERAPIES LTD, CHENGDU KANGHONG BIOTECHNOLOGIES CO LTD and NOVOZYMES DELTA LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | Australia | 2 | |
#3 | Canada | 2 | |
#4 | United Kingdom | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | China | 1 | |
#7 | Czechia | 1 | |
#8 | Hungary | 1 | |
#9 | Norway | 1 | |
#10 | Poland | 1 | |
#11 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Peptides | |
#3 | Medical preparations | |
#4 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Holms Rupert Donald | 16 |
Publication | Filing date | Title |
---|---|---|
GB9921881D0 | Regulatory/unfolding peptides of ezrin | |
GB9411534D0 | Preparation which inhibits the autoimmune response in HIV, or SLE, patients |